Sertraline
What it is
We have not added a short description yet.
Why it is on this page
People: source-defined population
DailyMed sertraline (Zoloft) label · checked Sep 20, 2026
Relationship: label-reported clinical studies for the Need
Scope: country:US
Pointer: /sections/2
Supporting passage: The effectiveness of ZOLOFT in the treatment of PD was demonstrated in three double‑blind, placebo‑controlled studies (Studies PD-1, PD-2, and PD‑3) of adult outpatients who had a primary diagnosis of PD (DSM‑III‑R), with or without agoraphobia.
Open sourceSource: DailyMed sertraline (Zoloft) label. Checked Sep 20, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/fda754f6-d0f3-4dce-a17a-927d64f912f7.xml
Research for Panic Disorder
Research suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
conclusion
The current ZOLOFT label reports three double-blind, placebo-controlled studies in adult outpatients with panic disorder. This bounded assessment does not compare every option or determine personal suitability.
DailyMed sertraline (Zoloft) label · checked Sep 20, 2026
Relationship: supports bounded conclusion
Scope: country:US
Pointer: /sections/2
Supporting passage: The effectiveness of ZOLOFT in the treatment of PD was demonstrated in three double‑blind, placebo‑controlled studies (Studies PD-1, PD-2, and PD‑3) of adult outpatients who had a primary diagnosis of PD (DSM‑III‑R), with or without agoraphobia.
Open sourceSource: DailyMed sertraline (Zoloft) label. Checked Sep 20, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/fda754f6-d0f3-4dce-a17a-927d64f912f7.xml
Compared with the others: Not directly compared. We show each option’s own research.